Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ZUHRE TUTUNCU

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1962435305
CMS profile
315374
Location
SAN DIEGO, CA

General Payments · PY2018–2024

$17,552.04

  • Reported across 116 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$5,304.63

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $3,060.00 3
Food and Beverage $2,244.63 32

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Janssen Biotech, Inc. $2,566.70 8
NOVARTIS PHARMACEUTICALS CORPORATION $740.00 3
Aurinia Pharma U.S., Inc. $739.81 8
ABBVIE INC. $436.38 2
GENZYME CORPORATION $392.36 4
Amgen Inc. $272.26 4
UCB, Inc. $56.62 2
GlaxoSmithKline, LLC. $52.43 2
Genentech USA, Inc. $30.38 1
ViiV Healthcare Company $17.69 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $546.01 11
PY2019 $568.01 10
PY2020 $2,186.05 8
PY2021 $2,664.88 5
PY2022 $5,194.51 28
PY2023 $1,087.95 19
PY2024 $5,304.63 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $425.00 10/18/2024 Consulting Fee Undisputed 01/23/2026 1106255411 CMS
ABBVIE INC. $11.38 12/10/2024 Food and Beverage Undisputed 01/23/2026 1106255413 CMS
Amgen Inc. $100.28 03/14/2024 Food and Beverage Undisputed 01/23/2026 1116187177 CMS
Amgen Inc. $24.36 05/16/2024 Food and Beverage Undisputed 01/23/2026 1117705800 CMS
Amgen Inc. $125.00 11/05/2024 Food and Beverage Undisputed 01/23/2026 1116187175 CMS
Amgen Inc. $22.62 12/05/2024 Food and Beverage Undisputed 01/23/2026 1117705802 CMS
Aurinia Pharma U.S., Inc. $75.84 01/05/2024 Food and Beverage Undisputed 01/23/2026 1150693701 CMS
Aurinia Pharma U.S., Inc. $122.17 02/14/2024 Food and Beverage Undisputed 01/23/2026 1150693703 CMS
Aurinia Pharma U.S., Inc. $119.12 02/17/2024 Food and Beverage Undisputed 01/23/2026 1150693705 CMS
Aurinia Pharma U.S., Inc. $44.72 03/14/2024 Food and Beverage Undisputed 01/23/2026 1150693707 CMS
Aurinia Pharma U.S., Inc. $25.09 09/06/2024 Food and Beverage Undisputed 01/23/2026 1150693709 CMS
Aurinia Pharma U.S., Inc. $140.00 09/27/2024 Food and Beverage Undisputed 01/23/2026 1150693711 CMS
Aurinia Pharma U.S., Inc. $78.98 10/12/2024 Food and Beverage Undisputed 01/23/2026 1150693713 CMS
Aurinia Pharma U.S., Inc. $133.89 11/15/2024 Food and Beverage Undisputed 01/23/2026 1150693715 CMS
Genentech USA, Inc. $30.38 07/16/2024 Food and Beverage Undisputed 01/23/2026 1133137122 CMS
GENZYME CORPORATION $138.93 02/14/2024 Food and Beverage Undisputed 01/23/2026 1139717628 CMS
GENZYME CORPORATION $105.25 02/16/2024 Food and Beverage Undisputed 01/23/2026 1139717662 CMS
GENZYME CORPORATION $87.00 11/15/2024 Food and Beverage Undisputed 01/23/2026 1139717732 CMS
GENZYME CORPORATION $61.18 11/17/2024 Food and Beverage Undisputed 01/23/2026 1139717730 CMS
GlaxoSmithKline, LLC. $29.38 07/11/2024 Food and Beverage Undisputed 01/23/2026 1116010507 CMS
GlaxoSmithKline, LLC. $23.05 09/27/2024 Food and Beverage Undisputed 01/23/2026 1116655985 CMS
Janssen Biotech, Inc. $17.29 05/22/2024 Food and Beverage Undisputed 01/23/2026 1078327440 CMS
Janssen Biotech, Inc. $95.58 07/03/2024 Food and Beverage Undisputed 01/23/2026 1078327593 CMS
Janssen Biotech, Inc. $51.10 09/25/2024 Food and Beverage Undisputed 01/23/2026 1078325054 CMS
Janssen Biotech, Inc. $17.38 09/25/2024 Food and Beverage Undisputed 01/23/2026 1078329343 CMS
Janssen Biotech, Inc. $48.96 09/27/2024 Food and Beverage Undisputed 01/23/2026 1078326358 CMS
Janssen Biotech, Inc. $2,160.00 09/27/2024 Consulting Fee Undisputed 01/23/2026 1078326863 CMS
Janssen Biotech, Inc. $123.59 11/16/2024 Food and Beverage Undisputed 01/23/2026 1078326144 CMS
Janssen Biotech, Inc. $52.80 11/18/2024 Food and Beverage Undisputed 01/23/2026 1078325545 CMS
Novartis Pharmaceuticals Corporation $128.60 02/15/2024 Food and Beverage Undisputed 01/23/2026 1087408116 CMS
Novartis Pharmaceuticals Corporation $475.00 02/15/2024 Consulting Fee Undisputed 01/23/2026 1087408118 CMS
Novartis Pharmaceuticals Corporation $136.40 11/16/2024 Food and Beverage Undisputed 01/23/2026 1087408122 CMS
UCB, Inc. $27.15 07/24/2024 Food and Beverage Undisputed 01/23/2026 1143241803 CMS
UCB, Inc. $29.47 10/04/2024 Food and Beverage Undisputed 01/23/2026 1143241807 CMS
ViiV Healthcare Company $17.69 06/20/2024 Food and Beverage Undisputed 01/23/2026 1112732483 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.